Literature DB >> 11979510

Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase in different tissues of mice: a possible mechanism of action.

Mahmoud A Mansour1, Mahmoud N Nagi, Aiman S El-Khatib, Abdullah M Al-Bekairi.   

Abstract

The present investigation focused, firstly, on the effects of oral administration of thymoquinone (TQ) on antioxidant enzyme activities, lipid peroxidation and DT-diaphorase activity in hepatic, cardiac and kidney tissues of normal mice. Superoxide dismutase (SOD; E.C:1.15.1.1), catalase (CAT; E.C:1.11.1.6), glutathione peroxidase (GSH-Px; E.C:1.11.1.9), glutathione-S-transferase (GST; E.C:2.5.1.18), and DT-diaphorase (E.C:1.6.99.2) enzyme activities in each tissue type were determined. Treatment of mice with the different doses of TQ (25, 50 and 100 mg kg(-1) day(-1) orally) for 5 successive days, produced significant reductions in hepatic SOD, CAT and GSH-Px activities. In addition cardiac SOD activity was markedly inhibited with the higher doses of TQ, (namely 50 and 100 mg kg(-1)). Moreover, TQ (100 mg kg(-1)) significantly reduced hepatic and cardiac lipid peroxidation as compared with the respective control group. Conversely, TQ (50,100 mg kg(-1)) and TQ (100 mg kg(-1)) enhanced cardiac and renal DT-diaphorase activity respectively. However, the selected doses of TQ neither produced any change in GST activity nor influenced reduced glutathione content in all tissues studied. TQ was tested, secondly, as a substrate for hepatic, cardiac and renal DT-diaphorase of normal mice in the presence of NADPH. Kinetic parameters for the reduction of TQ to dihydrothymoquinone (DHTQ) indicated that DT-diaphorase of different tissues can efficiently reduce TQ to DHTQ. K(m) and V(max) values revealed that hepatic DT-diaphorase exhibited the higher values, while the lower values were associated with renal DT-diaphorase. TQ and DHTQ were tested, thirdly, as specific scavengers for superoxide anion (generated biochemically) or as general scavengers for free radicals (generated photochemically). The results revealed that TQ and DHTQ acted not only as superoxide anion scavengers but also as general free radical scavengers. The IC(50) for TQ and DHTQ in biochemical and photochemical assays were in the nanomolar and micromolar range respectively. Our data may explain at least partly the reported beneficial in vivo protective effects of TQ through the combined antioxidant properties of TQ and its metabolite DHTQ. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979510     DOI: 10.1002/cbf.968

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  58 in total

Review 1.  Review on molecular and therapeutic potential of thymoquinone in cancer.

Authors:  Sanjeev Banerjee; Subhash Padhye; Asfar Azmi; Zhiwei Wang; Philip A Philip; Omer Kucuk; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.

Authors:  Equar Taka; Elizabeth A Mazzio; Carl B Goodman; Natalie Redmon; Hernan Flores-Rozas; Renee Reams; Selina Darling-Reed; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2015-06-27       Impact factor: 3.478

3.  Effect of thymoquinone, a constituent of Nigella sativa L., on ischemia-reperfusion in rat skeletal muscle.

Authors:  Hossein Hosseinzadeh; Samaneh Taiari; Marjan Nassiri-Asl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-22       Impact factor: 3.000

4.  The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-12-25

5.  The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; David Bauer; Karam F A Soliman
Journal:  Neurochem Res       Date:  2016-09-01       Impact factor: 3.996

6.  The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles.

Authors:  Badreldin H Ali; Mohammed Al Za'abi; Asem Shalaby; Priyadarsini Manoj; Mostafa I Waly; Javed Yasin; Mohamed Fahim; Abderrahim Nemmar
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-28

7.  Protective effect of thymoquinone against cisplatin-induced ototoxicity.

Authors:  Mustafa Sagit; Ferhat Korkmaz; Alper Akcadag; Mehmet Akıf Somdas
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-17       Impact factor: 2.503

8.  Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis.

Authors:  Abdelkader E Ashour; Adel R Abd-Allah; Hesham M Korashy; Sabry M Attia; Abdelrahman Z Alzahrani; Quaiser Saquib; Saleh A Bakheet; Hala E Abdel-Hamied; Shazia Jamal; Arun K Rishi
Journal:  Mol Cell Biochem       Date:  2014-01-08       Impact factor: 3.396

9.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

10.  Protective effect of thymoquinone against lead-induced hepatic toxicity in rats.

Authors:  Aymen Mabrouk; Imen Bel Hadj Salah; Wafa Chaieb; Hassen Ben Cheikh
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-14       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.